Physician profile
James Mersing
NPI 1003250515
$1,293.82
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,211 · 2021: $48.83 · 2024: $34.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $34.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $34.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $167.77 | 2019 | |
| Merck Sharp & Dohme LLC | $149.64 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $130.83 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $101.96 | 2019 | |
| Lilly USA, LLC | $71.11 | 2019 | |
| Pfizer INC. | $69.48 | 2019 | |
| Abbott Laboratories | $67.90 | 2019-2021 | |
| Amgen INC. | $56.58 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $51.43 | 2019 | |
| Janssen Pharmaceuticals, INC | $44.92 | 2019 | |
| Neos Therapeutics, LP | $43.54 | 2019 | |
| Abbvie INC. | $34.26 | 2024 | |
| Shire North American Group INC | $31.32 | 2019 | |
| Novartis Pharmaceuticals Corporation | $29.24 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $28.50 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $27.09 | 2019 | |
| Ethicon US, LLC | $25.61 | 2019 | |
| Tris Pharma INC | $25.42 | 2019 | |
| Astellas Pharma US INC | $25.13 | 2019 | |
| Genentech USA, INC. | $20.80 | 2019 | |
| Neurocrine Biosciences, INC. | $19.35 | 2019 | |
| Alkermes, INC. | $17.68 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.60 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $13.52 | 2019 | |
| Nalpropion Pharmaceuticals LLC | $12.35 | 2019 | |
| Ironwood Pharmaceuticals, INC | $11.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Mersing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.